Target intelligence / Profile preview

Septin 14 pseudogene 24 (SEPTIN14P24)

Target
SEPTIN14P24
Molecular classification
Other (specifically: "Pseudogene")
01

Overview

Septin 14 pseudogene 24 (SEPTIN14P24) is a pseudogene, meaning it is a segment of DNA that closely resembles a functional gene (in this case, presumably the SEPTIN14 gene) but has lost its protein-coding potential due to accumulated mutations. Pseudogenes like SEPTIN14P24 do not produce functional proteins. While some pseudogenes can have regulatory roles at the RNA level, such as acting as microRNA decoys or generating regulatory RNAs, there is no specific evidence that SEPTIN14P24 has such functions. Pseudogenes are not considered direct therapeutic drug targets and are typically used in genomic studies to understand genome evolution and organization[1][3][4]. This entry is not a therapeutic target because it is a pseudogene and not a protein, enzyme, transporter, or receptor with a druggable function. "SEPTIN14P24" does not encode a functional product and is not a known target in pharmacology or drug development[4]. The official gene nomenclature resource (HGNC) may not recognize this as a canonical gene symbol. While pseudogenes can sometimes play roles in diseases (e.g., by influencing expression of homologous genes), no such function is reported for SEPTIN14P24. There are no drugs, mechanisms of action, biomarkers, or safety issues associated with this pseudogene[1][3][4].

Other names
SEPT14P24
02

Biological functions

Other (pseudogenes generally do not encode proteins and do not have direct biological functions; some may play roles in regulation of gene expression through noncoding RNA mechanisms, but no such function is described for SEPTIN14P24 specifically)
03

Disease associations

Other (pseudogenes can sometimes be implicated in gene regulation or as biomarkers, but no direct disease role is described for this locus)

Beyond the preview

Go deeper on Septin 14 pseudogene 24 (SEPTIN14P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septin 14 pseudogene 24 (SEPTIN14P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call